Press release
Peptide Drug Conjugates Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global peptide drug conjugates market is anticipated to grow at a CAGR of 9.4% during the forecast period (2023-2030). A significant the market growth is anticipated to come from the extensive clinical trial pipeline for peptide drug conjugates, coupled with increased research and development expenditures for PDC development and the rising burden of disease globally. For instance, in July 2021, Takeda Pharmaceutical Co., Ltd., collaborated with PeptideDream, to invest $3.5 billion to develop peptide drugs for neuromuscular disease. Furthermore, pharmaceutical companies are developing PDCs as focused therapeutic treatments for diseases such as cancer, viral infections, and metabolic disorders. Further, the increasing agreement and acquisition for Peptide Drug Conjugates is projected to drive market growth by promoting increased acceptance and usage of these devices.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/peptide-drug-conjugates-market
• In November 2022, Exelixis, Inc., and Cybrexa Therapeutics Inc., entered into an exclusive collaboration agreement providing Exelixis the right to acquire CBX-12 (alphalex™ exatecan), a clinical-stage, first-in-class peptide-drug conjugate (PDC) that utilizes Cybrexa's proprietary alphalex technology to enhance delivery of exatecan to tumor cells.
• In June 2019, Peptidream Inc., a public Kanagawa-based biopharmaceutical company entered into a new Peptide Drug Conjugate collaboration agreement with Swiss-based Novartis AG. Under the agreement, PeptiDream used its proprietary Peptide Discovery Platform System (PDPS) technology for the identification of novel macrocyclic peptides for use as PDCs against multiple targets of interest selected by Novartis. Under the terms of the agreement, PeptiDream received an undisclosed upfront payment, R&D funding payments, and eligible to receive additional pre-clinical, clinical, approval, and commercial sales milestones.
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Type
o By Product
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Angiochem Inc., Bicycle Therapeutics, Inc., Cybrexa Therapeutics Inc., Oncopeptides AB, and Novartis AG, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Peptide Drug Conjugates Market Report Segment
By Type
• Diagnostic
• Therapeutic
By Product
• Melflufen
• Lutetium
• ANG1005
• BT1718
• CBX-12
A full report of Peptide Drug Conjugates Market available @ https://www.omrglobal.com/industry-reports/peptide-drug-conjugates-market
Global Peptide Drug Conjugates Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company Profiles
• AstraZeneca co.
• Camurus AB
• Chiasma, Inc.
• CRINETICS PHARMACEUTICALS
• Dauntless Pharmaceuticals
• Ipsen Biopharmaceuticals, Inc.
• Midatech Pharma PLC
• PeptiDream Inc.
• Peptron, Inc.
• Pfizer Inc.,
• Soricimed Biopharma
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Drug Conjugates Market Share, Trends, Growth, Analysis and Forecast 2023-2030 here
News-ID: 3357219 • Views: …
More Releases from Orion Market Research

Automotive Radar Sensors Market Rising Demand and Growth Forecast Through 2033
The global automotive radar sensors market was valued at USD 6.58 billion in 2024, with projections to reach USD 32.21 billion by 2033, growing at a CAGR of 18.5% from 2025 to 2033.
🧭 Automotive Radar Sensors Market Overview
The automotive radar sensors market is experiencing significant growth, driven by the increasing demand for advanced driver-assistance systems (ADAS) and the push towards autonomous driving technologies. Radar sensors are integral to features…

Automated Passenger Counting System Market Size, Shares, Business Growth and Upc …
In 2024, the Automated Passenger Counting System Market was valued at approximately USD 10.11 billion, and it is projected to reach around USD 22.69 billion by 2033, growing at an estimated CAGR of 9.4% between 2025 and 2033.
Automated Passenger Counting System Market Overview
The Automated Passenger Counting System Market is witnessing rapid growth driven by increasing demand for real-time transit data and operational efficiency in mass transportation systems. Transit agencies and…

Digital Transformation Market Size, Shares, Business Growth and Upcoming Trends …
In 2024, the global Digital Transformation Market was valued at approximately USD 809.12 billion, and it is projected to reach around USD 3,571.67 billion by 2033, growing at an estimated CAGR of 16.01% from 2025 to 2033.
Digital Transformation Market Overview
The Digital Transformation Market is witnessing robust expansion, driven by increased investments in AI, cloud computing, IoT, and machine learning to enhance operational efficiency, agility, and customer experiences. Government and enterprise-led…

Surgical Retractors Market Size, Shares, Business Growth and Upcoming Trends For …
In 2024, the Surgical Retractors Market was valued at approximately USD 2.09 billion, and it is projected to reach about USD 3.69 billion by 2033, growing at an estimated CAGR of 6.55% from 2025 to 2033.
Surgical Retractors Market Overview
The Surgical Retractors Market is steadily expanding, propelled by rising surgical volumes driven by aging populations, the prevalence of chronic diseases, and increased demand for elective procedures. Handheld retractors remain the…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…